Literature DB >> 4403844

The fate of ( 14 C)disodium cromoglycate in man.

S R Walker, M E Evans, A J Richards, J W Paterson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4403844     DOI: 10.1111/j.2042-7158.1972.tb09051.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  32 in total

1.  Relative bioavailability of sodium cromoglycate to the lung following inhalation, using urinary excretion.

Authors:  O A Aswania; S A Corlett; H Chrystyn
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

Review 2.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

3.  Delivery of therapeutic aerosols to intubated babies.

Authors:  J Grigg; S Arnon; T Jones; A Clarke; M Silverman
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

4.  Bioavailability prediction based on molecular structure for a diverse series of drugs.

Authors:  Joseph V Turner; Desmond J Maddalena; Snezana Agatonovic-Kustrin
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

5.  Absorption of drugs by the lung.

Authors:  G M Shenfield; M E Evans; J W Paterson
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

6.  Is inhibition of mast cell mediator release relevant to the clinical activity of anti-allergic drugs?

Authors:  M K Church
Journal:  Agents Actions       Date:  1986-06

7.  The absorption and elimination of ICI 74,917 in man.

Authors:  M E Pickup; A J Johnson; C S May; J W Paterson; M P Harrison
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

8.  [Spectrum of hypereosinophilia syndrome based on 2 clinical case reports].

Authors:  H Nolte; U Helmchen
Journal:  Med Klin (Munich)       Date:  1998-07-15

9.  Disposition of disodium cromoglycate administered in three particle sizes.

Authors:  S H Curry; A J Taylor; S Evans; S Godfrey; E Zeidifard
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

10.  Inhibition of immediate hypersensitivity reactions in the rat by disodium cromoglycate and nitroindanedione.

Authors:  B A Spicer; J W Ross; H Smith
Journal:  Clin Exp Immunol       Date:  1975-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.